Related Experiment Video
Updated: Jul 1, 2026
08:47
Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Active immunization alters the plasma nicotine concentration in rats
Y Hieda1, D E Keyler, J T Vandevoort
1Minneapolis Medical Research Foundation, Minneapolis, Minnesota, USA.
The Journal of Pharmacology and Experimental Therapeutics
|February 12, 1998
Summary
Active immunization with a nicotine conjugate increased nicotine binding in rat plasma, but did not alter brain nicotine levels. This approach shows potential for nicotine distribution modification, though improved immunogens may be needed.
Area of Science:
- Pharmacology
- Immunology
- Neuroscience
Background:
- Active immunization strategies are explored to modulate drug distribution.
- Nicotine's distribution and effects are influenced by its binding in plasma.
Purpose of the Study:
- To investigate the efficacy of active immunization in altering nicotine distribution in rats.
- To assess the impact of anti-nicotine antibodies on nicotine levels in plasma and brain.
Main Methods:
- Rats were immunized with a nicotine-keyhole limpet hemocyanin conjugate (CMUNic-KLH).
- Antibody titers, affinity, and binding capacity were quantified.
- Nicotine distribution was analyzed in plasma and brain after intravenous nicotine administration in immunized and control rats.
Main Results:
- Immunization generated high-titer antibodies against nicotine and the linker structure.
- Plasma nicotine concentrations were significantly higher in immunized rats, indicating increased nicotine binding.
- Despite increased plasma binding, brain nicotine concentrations did not differ between groups.
Conclusions:
- Active immunization can bind a significant portion of systemically administered nicotine in plasma.
- Current antibody levels and affinity are insufficient to alter nicotine brain distribution.
- Development of more potent immunogens is necessary to modify nicotine's central effects.
Related Concept Videos
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...